HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joan R Butterton Selected Research

Imipenem Drug Combination Cilastatin (Primaxin)

12/2021A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
3/2020Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
1/2020Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
1/2018Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.
1/2018Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joan R Butterton Research Topics

Disease

22Infections
11/2021 - 03/2015
5Bacterial Pneumonia
01/2022 - 01/2018
3Bacterial Infections (Bacterial Infection)
03/2020 - 01/2020
3Fibrosis (Cirrhosis)
11/2017 - 07/2015
2Healthcare-Associated Pneumonia
01/2022 - 12/2019
2Critical Illness (Critically Ill)
12/2021 - 12/2019
2Cytomegalovirus Infections (Inclusion Disease)
10/2020 - 01/2018
2Ventilator-Associated Pneumonia
01/2020 - 12/2019
2Coinfection
11/2017 - 03/2013
2Chronic Hepatitis C
11/2017 - 07/2015
2Hepatitis C
01/2016 - 03/2013
1COVID-19
10/2022
1Bacteremia
11/2021
1Breast Neoplasms (Breast Cancer)
02/2021
1Hypercholesterolemia
02/2021
1Gram-Negative Bacterial Infections
03/2020
1Acute Kidney Injury (Acute Renal Failure)
03/2020
1Renal Insufficiency (Renal Failure)
03/2020
1Intraabdominal Infections
01/2020
1Urinary Tract Infections (Urinary Tract Infection)
01/2020
1Chronic Renal Insufficiency
05/2019
1Chronic Kidney Failure (Chronic Renal Failure)
05/2019
1HIV Infections (HIV Infection)
01/2019
1End Stage Liver Disease
12/2017
1Persistent Infection
12/2017
1Hepatocellular Carcinoma (Hepatoma)
12/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2017
1Abscess
11/2017
1Keratitis
11/2017
1Tuberculosis (Tuberculoses)
07/2017
1Fabry Disease (Fabry's Disease)
10/2006
1Edema (Dropsy)
04/2006

Drug/Important Bio-Agent (IBA)

9grazoprevirIBA
05/2019 - 07/2015
8elbasvirIBA
05/2019 - 07/2015
6relebactamIBA
12/2021 - 01/2018
5Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
12/2021 - 01/2018
5Pharmaceutical PreparationsIBA
12/2019 - 06/2015
3Meropenem (Merrem)FDA LinkGeneric
01/2022 - 12/2019
3tazobactam drug combination ceftolozaneIBA
01/2022 - 12/2019
3letermovirIBA
10/2020 - 01/2018
3Colistin (Coly-Mycin)FDA Link
03/2020 - 01/2020
3ImipenemFDA Link
03/2020 - 01/2020
3Ribavirin (Virazole)FDA LinkGeneric
11/2017 - 06/2015
2Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2019
2tedizolid phosphateIBA
01/2021 - 01/2021
2terminaseIBA
01/2020 - 01/2018
2Protease Inhibitors (Protease Inhibitor)IBA
01/2019 - 06/2015
2Methadone (Dolophine)FDA LinkGeneric
11/2018 - 03/2015
2Antiviral Agents (Antivirals)IBA
01/2018 - 11/2017
2InterferonsIBA
11/2017 - 07/2015
2RNA (Ribonucleic Acid)IBA
11/2017 - 11/2017
2ruzasvirIBA
11/2017 - 11/2017
2uprifosbuvirIBA
11/2017 - 11/2017
2doravirineIBA
07/2017 - 01/2017
2NucleosidesIBA
07/2017 - 01/2017
2Reverse Transcriptase InhibitorsIBA
07/2017 - 01/2017
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
06/2015 - 03/2013
1molnupiravirIBA
10/2022
1TazobactamFDA LinkGeneric
01/2022
1ceftolozaneIBA
01/2022
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
12/2021
1Rosuvastatin Calcium (Crestor)FDA Link
02/2021
1Atorvastatin (Lipitor)FDA Link
02/2021
1Pravastatin (Pravachol)FDA LinkGeneric
02/2021
1pitavastatin (itavastatin)FDA Link
02/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2021
1AnionsIBA
02/2021
1Peptides (Polypeptides)IBA
02/2021
1Linezolid (Zyvox)FDA Link
01/2021
1ProdrugsIBA
01/2021
1Oxazolidinones (2 Oxazolidone)IBA
01/2021
1Carbapenems (Carbapenem Antibiotics)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Rifampin (Rifampicin)FDA LinkGeneric
07/2017
1dolutegravirIBA
01/2017
1IntegrasesIBA
01/2017
1EnzymesIBA
01/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2015
1Opioid Analgesics (Opioids)IBA
03/2015
1Naloxone Drug Combination BuprenorphineFDA Link
03/2015
1globotriaosylceramide (globotriosylceramide)IBA
10/2006
1alpha-Galactosidase (Beano)IBA
10/2006
1GlycosphingolipidsIBA
10/2006
1Shiga Toxin (Shigella Toxin)IBA
10/2006
1Phenobarbital (Luminal)FDA Link
04/2006

Therapy/Procedure

8Therapeutics
03/2020 - 06/2015
4Mechanical Ventilators (Ventilator)
01/2022 - 01/2021
2Cell Transplantation
10/2020 - 01/2020
1Artificial Respiration (Mechanical Ventilation)
12/2019
1Oral Administration
01/2018